UM  > Institute of Chinese Medical Sciences
Residential Collegefalse
Status已發表Published
Pulchinenoside E4 sensitizes chemotherapy against breast cancer through blocking autophagic flux
ZHAO Yuxin; HE CHENGWEI
2022-10
PublisherInternal communicationa
Conference Name8th Macau Symposium on Biomedical Science 2022 (MSBS2022)
Conference PlaceMacau
Conference Date2022-10-14--2022-10-15
CountryChina
AbstractAutophagy is an intracellular protective process involving degradation of misfolded proteins, damaged organelles and nucleic acids in lysosomes to maintain homeostasis under stressful conditions. Present evidence shows that autophagy inhibitors can improve the pathologic tumor and serum biomarkers responding to chemotherapeutic drugs. Pulchinenoside E4 (PSE4) is a triterpenoid isolated from Pulsatilla chinensis (Bunge) Regel, a traditional Chinese medicinal herb used for the treatment of inflammation and infection. It was reported that some triterpenoids exhibited anti-cancer and autophagy inhibitory effect. The present study focuses on the autophagy inhibition caused by PSE4 and its underlying mechanisms, as well as its synergistic anti-breast cancer activity. Results revealed that PSE4 induced autophagosome formation but interrupted the autophagosome-lysosome fusion process in breast cancer cells (MCF-7 and MDA-MB-231 cell lines). As a result, autophagic flux was inhibited. Alexa Fluor 594-conjugated CTxB staining showed that lysosomal lipid rafts were disrupted by PSE4. However, when adding cholesterol, which is protective to lipid rafts, the decreased fluorescence of CTxB caused by PSE4 was partially recovered, further demonstrating the destructive effect of PSE4 on lipid rafts. The variation of protein LC3I, LC3II and p62 suggested this lipid raft disruption was directly related to the autophagic flux inhibition. Lysosomal acidification and activation of cathepsins in lysosomes were also interfered. PSE4 significantly elevated lysosomal pH, which is comparable to chloroquine, a known lysosomal alkalizing agent that strongly inhibited autophagy. Inhibition of cathepsin activity in lysosomes has been proved to be associated with increased lysosomal pH and lipid rafts destruction on lysosome membrane. Furthermore, inhibition of autophagy by PSE4 (1.5, 3, 6 μM) could enhance the anti-breast cancer activity of 5-fluorouracil in vitro and in vivo. Taken together, PSE4 inhibits autophagic flux and thereby sensitizes chemotherapy against breast cancer through disrupting lysosomal structure and function.
KeywordPulchinenoside E4 Breast Cancer Chemotherapy Autophagy Lipid Rafts
Document TypeConference proceedings
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorHE CHENGWEI
AffiliationUniversity of Macau
First Author AffilicationUniversity of Macau
Recommended Citation
GB/T 7714
ZHAO Yuxin,HE CHENGWEI. Pulchinenoside E4 sensitizes chemotherapy against breast cancer through blocking autophagic flux[C]:Internal communicationa, 2022.
Files in This Item: Download All
File Name/Size Publications Version Access License
2022 8th Macau Sympo(29175KB)会议录 开放获取CC BY-NC-SAView Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[ZHAO Yuxin]'s Articles
[HE CHENGWEI]'s Articles
Baidu academic
Similar articles in Baidu academic
[ZHAO Yuxin]'s Articles
[HE CHENGWEI]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[ZHAO Yuxin]'s Articles
[HE CHENGWEI]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: 2022 8th Macau Symposium on Biomedical Science-ZYX.pdf
Format: Adobe PDF
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.